Genetic Engineering & Biotechnology News - March 8, 2022
Evripidis Gavathiotis, Ph.D., comments on his discovery of a highly promising strategy for overcoming a key cause of cancer deaths: the ability of cancer cells to thrive in the face of chemotherapy drugs designed to destroy them. Dr. Gavathiotis is professor of biochemistry and of medicine at Einstein and co-leader of the Cancer Therapeutics Program at the NCI-designated Albert Einstein Cancer Center.
Dr. Gavathiotis's ProfileMore coverage on Dr. Gavathiotis
UPI - March 7, 2022
Amit Verma, M.B.B.S., discusses his study that found first responders who were at the World Trade Center on 9/11 have two to three times the number of blood cell mutations that are linked to leukemia, heart attacks, diabetes, and asthma compared to first responders who were not at the site. Dr. Verma is associate director for translational science at the NCI-designated Albert Einstein Cancer Center, professor of medicine and of developmental and molecular biology at Einstein, and director of hemato-oncology at Montefiore.
Additional coverage includes MedPage Today, Boston Herald, ASCO Post
Dr. Verma's ProfileMore coverage on Dr. Verma
The New York Times - February 25, 2022
Hina Talib, M.D., suggests parents look for signs that their children are anxious about the war in Ukraine and offers advice on how to discuss the topic with them. Dr. Talib is associate professor of pediatrics and of obstetrics & gynecology and women's health at Einstein and a pediatrician at the Children's Hospital at Montefiore.
Dr. Talib's ProfileMore coverage on Dr. Talib
The Philadelphia Inquirer - February 21, 2022
Deepika Slawek, M.D., M.P.H., M.S., says there is scant evidence to support the use of medical cannabis to treat opioid use disorder, and that buprenorphine and methadone are the primary treatments that should be prescribed. Dr Slawek is assistant professor of medicine at Einstein and an internist and addiction medicine specialist at Montefiore.
Additional coverage includes NPR affiliate 90.5 WESA (Hear Dr. Slawek at 13:15 and 16:30)
Dr. Slawek's ProfileMore coverage on Dr. Slawek
AAMC News - February 15, 2022
Brianna Norton, D.O., M.P.H., talks about the need to provide healthcare to people who inject drugs, including those who use one of the city's first overdose prevention centers. Dr. Norton is associate professor of medicine at Einstein and an internist and infectious disease specialist at Montefiore.
Dr. Norton's Profile
CBS Mornings - February 15, 2022
Shelby Harris, Psy.D., discusses a new study showing that increased sleep may reduce appetite and help with weight loss. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein.
Dr. Harris's ProfileMore coverage on Dr. Harris
Scientific American - January 25, 2022
Betsy Herold, M.D., discusses the innate immune response, which her 2020 research showed was responsible for children's robust response to COVID-19, but she notes that mutations in new viral variants may have an impact on innate immunity. Dr. Herold is chief of infectious diseases and vice chair for research in the department of pediatrics at Einstein and the Children's Hospital at Montefiore and the Harold and Muriel Block Chair in Pediatrics at Einstein.
Dr. Herold's ProfileMore coverage on Dr. Herold
The Wall Street Journal - January 11, 2022
Nir Barzilai, M.D., talks about plans for a clinical trial to study metformin, a diabetes drug, as an anti-aging medicine that may delay the onset of cardiovascular disease, dementia, and other age-related diseases. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Medscape - January 10, 2022
Kartik Chandran, Ph.D., and Denise Haslwanter, Ph.D., describe their study that finds the human antibody response induced by the widely used yellow fever vaccine has reduced activity against the recent Brazilian strain of the virus. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology at Einstein. Dr. Haslwanter is a research fellow in Dr. Chandran's lab.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
The New York Times - January 8, 2022
In a letter to the editor, written in response to a story about false positives in prenatal genetic testing, Susan Klugman, M.D., explains that these tests, like mammography, are for screening, not diagnosis, and that healthcare practitioners with appropriate training must provide genetic counseling to parents prior to testing. Dr. Klugman is professor of pediatrics and of obstetrics & gynecology and women's health at Einstein, and director of reproductive and medical genetics at Montefiore.
Dr. Klugman's ProfileMore coverage on Dr. Klugman
US News & World Report - January 6, 2022
Richard Lipton, M.D., comments on a study highlighting the connection between heart and brain health, particularly in women. Dr. Lipton is professor in the Saul R. Korey Department of Neurology, of psychiatry and behavioral sciences, and of epidemiology & population health and holds the Edwin S. Lowe Professor at Einstein, and is vice chair of neurology at Einstein and Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
The Washington Post - December 21, 2021
Liise-anne Pirofski, M.D., says the Federal Drug Administration should expand the use of convalescent plasma to outpatient use to help fight COVID-19, particularly during the current surge of the omicron variant. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Additional coverage includes The Scientist
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski